HMS Holdings Corp

HMS — Q4 and FY2013 Earnings Presentation

18 slides from HMS's earnings presentation, Feb 28, 2014

  1. Slide 1: Q4 and Full Year 2013 Investor Call

    Q4 and Full Year 2013 Investor Call February 28, 2014 Bill Lucia, President and CEO Walter Hosp, CFO

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement 2 This presentation contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 These forward-looking statements are based on current expectations, estimates, assumptions and projections that are subject to change. Shoul

  3. Slide 3: Discussion Outline

    Discussion Outline 3 Q4 and Full Year Financial Results Q4 Sales External Environment and Market Drivers Medicare RAC Medicaid Growth Commercial Market New Executives 2014-2015 Growth and Profitability

  4. Slide 4: Consolidated Statements of Income

    Consolidated Statements of Income 4 ($ in thousands except per share amounts) Three months ended Year ended 31-Dec-13 % y/y 31-Dec-13 % y/y Revenue $ 121,592 (9%) $ 491,762 4% Cost of services expenses 84,879 0% 345,883 8% Selling, general & administrative expenses 16,452 45% 68,701 24% Total operat

  5. Slide 5: Quarterly Revenue

    Quarterly Revenue 5 (in $ Millions) 0 110 115 120 125 130 135 2013 Avg $122.9M 2012 Avg. $118.4M Q1 107.3 116.6 Q2 120.1 125.8 Q3 113.2 127.8 Q4 133.1 121.6 2012 Act 2013 Act

  6. Slide 6: Quarterly Revenue Without Medicare RAC

    Quarterly Revenue Without Medicare RAC 6 (in $ Millions) 0 90 92 94 96 98 100 102 104 106 108 110 2012 Avg. 97.0 2013 Avg. 96.0 Q1 88.1 93.8 Q2 101.6 99.0 Q3 90.0 Q4 108.4 2012 Avg. 97.0 2013 Avg. 96.0 94.7 96.2 2012 Act 2013 Act

  7. Slide 7: 2013 Financial Results

    2013 Financial Results 7 Revenue ($M) OpEx ($M) Adj. EPS ($) Adj. EBITDA ($M) 2012 Act: $473.7 2013 Act: $491.8 2012 Act: $374.2 2013 Act: $414.6 2012 Act: $160.2 2013 Act: $144.9 2012 Act: $0.86 2013 Act: $0.75 0 110 115 120 125 130 135 2013 Avg. 2012 Avg. Q1 107.3 116.6 Q2 120.1 125.8 Q3 113.2 127

  8. Slide 8: 2014 Outlook Medicare RAC

    Without MC RAC 2014 Outlook 8 Medicare RAC

  9. Slide 9: A Diversified Market and Product Mix

    A Diversified Market and Product Mix Medicare RAC Commercial 0-2% 25-30% 2014 Growth Rates v COB Program Integrity 8-10% 20-25% 2013 Revenue By Product 2013 Revenue By Market 2014 Growth Rates 43% 30% 22% 9 5% Other Federal State Medicare RAC 61% 22% 17%

  10. Slide 10: Q4 Sales

    Q4 Sales 10 State Government California TPL (reprocurement with additional scope) Florida and Texas long-term care audits Maine TPL (extension) Massachusetts TPL (extension) Minnesota (RAC extension) North Carolina TPL and RAC (contract extensions) Virginia: DRG audit (re-procurement) Wisconsin: RAC

  11. Slide 11: External Environment/Market Drivers

    External Environment/Market Drivers 11 Medicare RAC program Medicaid growth and mix Commercial market

  12. Slide 12: Medicare RAC Procurement Timeline

    Medicare RAC Procurement Timeline 12

  13. Slide 13: Medicare RAC Program

    Medicare RAC Program 13 * CMS data from CMS RAC Program Reports; Medicare RAC program is the most effective way to control costs Momentum seen in the procurement process Enhancements required to improve the program for all stakeholders FFY Total Corrections* (in $ Millions)

  14. Slide 14: Medicaid is Growing

    Medicaid is Growing NOTE: Enrollment percentage changes from June to June of each year. Spending growth percentages in state fiscal year. SOURCE: Medicaid Enrollment June 2013 Data Snapshot, KCMU, August 2013. Spending Data from KCMU Analysis of CMS Form 64 Data for Historic Medicaid Growth Rates. F

  15. Slide 15: HMS Advantages in Commercial Sector

    15 HMS Advantages in Commercial Sector Enrollment (in millions) Expenditures ($ billions) 1.6% 7% 7.7 % 24.2% Broad array of products Strong MCO relationships End-to-end solutions Proprietary datasets Analytics and clinical expertise

  16. Slide 16: New Leaders

    New Leaders 16 20 years in the healthcare information technology Former VP of Architecture & Technology for Regence (Blue Cross Blue Shield) Developed flagship platform and benefits and claims processing system for health plans and self-insured employer groups Cynthia Nustad Former Senior VP of Clai

  17. Slide 17: Summary

    Medicaid expansion begins Significant growth in commercial New talent Revenue growth in low teens* Operating margins expanding 5%-6%* v Full-year benefit of new Medicaid lives Acceleration of commercial revenue Across the board revenue growth Further margin expansion Resumption of Medicare RAC growt

  18. Slide 18: Powering healthcare with integrity

    @hms Powering healthcare with integrity

HMS Holdings — Q4 and FY2013 Earnings Presentation on 6ix